Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - gramicidin, quantity: 0.25 mg/g; triamcinolone acetonide, quantity: 1 mg/g; nystatin, quantity: 100000 u/g; neomycin sulfate (equivalent: neomycin, qty 2.5 mg/g) - ointment - excipient ingredients: polyethylene; liquid paraffin - kenacomb is indicated for the relief of the inflammatory and pruritic manifestations of dermatoses likely to become or which are already infected.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - triamcinolone acetonide, quantity: 10 mg/ml - injection, suspension - excipient ingredients: carmellose sodium; polysorbate 80; benzyl alcohol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - intra-articular: kenacort-a 10 injection (sterile triamcinolone acetonide suspension usp) is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute non-specific tenosynovitis, post-traumatic osteoarthritis. intradermal: intralesional administration of kenacort-a 10 injection is indicated for the treatment of keloids, discoid lupus erythermatous, necrobiosis lipoidica diabeticorum, alopecia areata and localised hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare, and lichen simplex chronicus ( neurodermatitis), kenacort-a 10 injection also may be useful in cystic tumours of an aponeurosis or tendon ( ganglia).

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - triamcinolone acetonide, quantity: 40 mg/ml - injection, suspension - excipient ingredients: benzyl alcohol; sodium chloride; polysorbate 80; carmellose sodium; water for injections; sodium hydroxide; hydrochloric acid - intramuscular: the intramuscular administration of kenacort-a 40 (sterile triamcinolone acetonide suspension usp) is indicated for systemic corticosteroid therapy in such conditions as allergic diseases, dermatoses, or generalised rheumatoid arthritis and other connective tissue disorders. intramuscular administration is particularly valuable in such conditions where oral corticosteroid therapy is not feasible. intra-articular: kenacort-a 40 injection is indicated for intra-articular or intrasynovial administration and for injections into tendon sheaths as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis; rheumatoid arthritis; acute and subacute bursitis; acute gouty arthritis; epicondylitis; acute non-specific tenosynovitis; post-traumatic osteoarthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 1 mg/g; nystatin, quantity: 100000 u/g; gramicidin, quantity: 0.25 mg/g; neomycin sulfate (equivalent: neomycin, qty 2.5 mg/g) - ointment - excipient ingredients: polyethylene; liquid paraffin - treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene. kenacomb otic is only recommended for short-term use.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - triamcinolone acetonide 10 mg/ml; triamcinolone acetonide 10 mg/ml - suspension for injection - 10 mg/ml - active: triamcinolone acetonide 10 mg/ml excipient: benzyl alcohol carmellose sodium polysorbate 80 sodium chloride water for injection active: triamcinolone acetonide 10 mg/ml excipient: benzyl alcohol carmellose sodium polysorbate 80 sodium chloride water for injection - intra-articular: kenacort-a 10 injection is indicated for intra-articular or intra-synovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis, post-traumatic osteoarthritis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - triamcinolone acetonide 40 mg/ml; triamcinolone acetonide 40 mg/ml - suspension for injection - 40 mg/ml - active: triamcinolone acetonide 40 mg/ml excipient: benzyl alcohol carmellose sodium polysorbate 80 sodium chloride water for injection active: triamcinolone acetonide 40 mg/ml excipient: benzyl alcohol carmellose sodium polysorbate 80 sodium chloride water for injection - intramuscular: the intramuscular administration of kenacort-a 40 (sterile triamcinolone acetonide suspension usp) is indicated for systemic corticosteroid therapy in such conditions as allergic diseases, dermatoses, or generalised rheumatoid arthritis and other connective tissue disorders. intramuscular administration is particularly valuable in such conditions when oral corticosteroid therapy is not feasible.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nystatin, quantity: 90000 u/ml; triamcinolone acetonide, quantity: 0.9 mg/ml; gramicidin, quantity: 0.225 mg/ml; neomycin sulfate (equivalent: neomycin, qty 2.25 mg/ml) - ear drops, solution - excipient ingredients: polyethylene; liquid paraffin - treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene

Australia - English - Department of Health (Therapeutic Goods Administration)

neomycin; gramicidin; triamcinolone acetonide; nystatin -

Australia - English - Department of Health (Therapeutic Goods Administration)

neomycin; triamcinolone acetonide; gramicidin; nystatin -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - budesonide - spray - 64microgram/1dose